• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用鲍曼不动杆菌的天然 I 型 CRISPR-Cas 系统进行基因组编辑和基因抑制。

Harnessing the Native Type I-F CRISPR-Cas System of Acinetobacter baumannii for Genome Editing and Gene Repression.

机构信息

State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China; College of Life Science, University of Chinese Academy of Sciences, Beijing, China.

State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

出版信息

Int J Antimicrob Agents. 2023 Nov;62(5):106962. doi: 10.1016/j.ijantimicag.2023.106962. Epub 2023 Sep 4.

DOI:10.1016/j.ijantimicag.2023.106962
PMID:37673355
Abstract

INTRODUCTION

The rapid emergence of infections caused by multidrug-resistant Acinetobacter baumannii (A. baumannii) has posed a serious threat to global public health. It has therefore become important to obtain a deeper understanding of the mechanisms of multidrug resistance and pathogenesis of A. baumannii; however, there are still relatively few genetic engineering tools for this. Although A. baumannii possesses Type I-F CRISPR-Cas systems, they have not yet been used for genetic modifications.

METHODS

A single plasmid-mediated native Type I-F CRISPR-Cas system for gene editing and gene regulation in A. baumannii was developed. The protospacer adjacent motif sequence was identified as 5'-NCC-3' by analysis of the CRISPR array.

RESULTS

Through introduction of the RecAb homologous recombination system, the knockout efficiency of the oxyR gene significantly increased from 12.5% to 75.0% in A. baumannii. To investigate transcriptional inhibition by the Type I-F CRISPR system, the gene encoding its Cas2-3 nuclease was deleted and the native Type I-F Cascade effector was repurposed to regulate transcription of alcohol dehydrogenase gene adh4. The level of adh4 transcription was inhibited by up to 900-fold compared with the control. The Cascade transcriptional module was also successfully applied in a clinical Klebsiella pneumoniae isolate.

CONCLUSION

This study proposed a tool for future exploration of the genetic characteristics of A. baumannii or other clinical strains.

摘要

简介

多重耐药鲍曼不动杆菌(A.baumannii)引起的感染迅速出现,对全球公共卫生构成了严重威胁。因此,深入了解 A.baumannii 的多药耐药机制和发病机制变得尤为重要;然而,目前用于该菌的遗传工程工具仍然相对较少。尽管 A.baumannii 拥有 I 型-F CRISPR-Cas 系统,但尚未将其用于遗传修饰。

方法

开发了一种用于 A.baumannii 基因编辑和基因调控的单质粒介导的天然 I 型-F CRISPR-Cas 系统。通过对 CRISPR 阵列的分析,确定前间区序列基序序列为 5'-NCC-3'。

结果

通过引入 RecAb 同源重组系统,oxyR 基因的敲除效率从 A.baumannii 中的 12.5%显著提高到 75.0%。为了研究 I 型-F CRISPR 系统的转录抑制作用,删除了编码其 Cas2-3 核酸酶的基因,并重新利用天然 I 型-F Cascade 效应物来调节醇脱氢酶基因 adh4 的转录。adh4 转录水平与对照相比抑制了 900 倍。Cascade 转录模块也成功应用于临床分离的肺炎克雷伯菌。

结论

本研究提出了一种用于未来探索 A.baumannii 或其他临床菌株遗传特征的工具。

相似文献

1
Harnessing the Native Type I-F CRISPR-Cas System of Acinetobacter baumannii for Genome Editing and Gene Repression.利用鲍曼不动杆菌的天然 I 型 CRISPR-Cas 系统进行基因组编辑和基因抑制。
Int J Antimicrob Agents. 2023 Nov;62(5):106962. doi: 10.1016/j.ijantimicag.2023.106962. Epub 2023 Sep 4.
2
A Highly Efficient CRISPR-Cas9-Based Genome Engineering Platform in Acinetobacter baumannii to Understand the HO-Sensing Mechanism of OxyR.在鲍曼不动杆菌中基于高效 CRISPR-Cas9 的基因组工程平台,以了解 OxyR 的 HO 感应机制。
Cell Chem Biol. 2019 Dec 19;26(12):1732-1742.e5. doi: 10.1016/j.chembiol.2019.09.003. Epub 2019 Sep 20.
3
CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous .鲍曼不动杆菌中的 CRISPR-Cas 通过靶向内源性 . 有助于抗生素敏感性。
Microbiol Spectr. 2022 Aug 31;10(4):e0082922. doi: 10.1128/spectrum.00829-22. Epub 2022 Aug 8.
4
A -Based Efficient Genetic Manipulation Platform in Acinetobacter baumannii To Explore the Vital DNA Components of Adaptive Immunity for I-F CRISPR-Cas.基于 A 的鲍曼不动杆菌高效遗传操作平台,探索 I-F CRISPR-Cas 适应性免疫的重要 DNA 成分
Microbiol Spectr. 2022 Oct 26;10(5):e0195722. doi: 10.1128/spectrum.01957-22. Epub 2022 Sep 1.
5
CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in .基于 CRISPR-Cas9 的基因组编辑和胞嘧啶碱基编辑在 。
STAR Protoc. 2020 Jun 3;1(1):100025. doi: 10.1016/j.xpro.2020.100025. eCollection 2020 Jun 19.
6
Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.利用内源性 CRISPR-Cas 系统对酪丁酸梭菌进行多重基因组编辑,并对该菌株进行工程改造以提高丁醇产量。
Metab Eng. 2018 May;47:49-59. doi: 10.1016/j.ymben.2018.03.007. Epub 2018 Mar 9.
7
The Involvement of the Gene in the Antimicrobial Resistance of .该基因在……的抗菌耐药性中的作用。 (你提供的原文不完整,推测是这个意思,具体需结合完整原文准确翻译)
Front Med (Lausanne). 2022 Jan 26;9:797104. doi: 10.3389/fmed.2022.797104. eCollection 2022.
8
CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.CRISPR-Cas9 和 CRISPR 辅助胞嘧啶脱氨酶可实现肺炎克雷伯氏菌的精确和高效基因组编辑。
Appl Environ Microbiol. 2018 Nov 15;84(23). doi: 10.1128/AEM.01834-18. Print 2018 Dec 1.
9
CRISPR-Based Gene Editing in to Combat Antimicrobial Resistance.基于CRISPR的基因编辑用于对抗抗菌药物耐药性。
Pharmaceuticals (Basel). 2023 Jun 23;16(7):920. doi: 10.3390/ph16070920.
10
Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms.鲍曼不动杆菌 NCIMB8209:一种罕见的环境菌株,表现出广泛的插入序列介导的基因组重排,导致暴露的细胞结构和防御机制丢失。
mSphere. 2020 Jul 29;5(4):e00404-20. doi: 10.1128/mSphere.00404-20.

引用本文的文献

1
Research Progress on the Mechanism and Application of the Type I CRISPR-Cas System.I型CRISPR-Cas系统的作用机制及应用研究进展
Int J Mol Sci. 2024 Nov 22;25(23):12544. doi: 10.3390/ijms252312544.
2
H-NS is a Transcriptional Repressor of the CRISPR-Cas System in Acinetobacter baumannii ATCC 19606.H-NS 是鲍曼不动杆菌 ATCC 19606 中 CRISPR-Cas 系统的转录抑制剂。
J Microbiol. 2024 Nov;62(11):999-1012. doi: 10.1007/s12275-024-00182-5. Epub 2024 Nov 11.